USANA Health Sciences Revenue 2006-2019 | USNA

USANA Health Sciences revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
USANA Health Sciences Annual Revenue
(Millions of US $)
2018 $1,189
2017 $1,047
2016 $1,006
2015 $918
2014 $790
2013 $718
2012 $649
2011 $582
2010 $518
2009 $437
2008 $429
2007 $423
2006 $365
2005 $315
USANA Health Sciences Quarterly Revenue
(Millions of US $)
Q1 2019 $273
Q4 2018 $299
Q3 2018 $297
Q2 2018 $301
Q1 2018 $292
Q4 2017 $273
Q3 2017 $262
Q2 2017 $257
Q1 2017 $255
Q4 2016 $253
Q3 2016 $254
Q2 2016 $259
Q1 2016 $240
Q4 2015 $233
Q3 2015 $233
Q2 2015 $233
Q1 2015 $219
Q4 2014 $228
Q3 2014 $192
Q2 2014 $188
Q1 2014 $182
Q4 2013 $186
Q3 2013 $174
Q2 2013 $189
Q1 2013 $169
Q4 2012 $169
Q3 2012 $165
Q2 2012 $161
Q1 2012 $154
Q4 2011 $146
Q3 2011 $144
Q2 2011 $149
Q1 2011 $144
Q4 2010 $138
Q3 2010 $135
Q2 2010 $126
Q1 2010 $119
Q4 2009 $117
Q3 2009 $111
Q2 2009 $112
Q1 2009 $97
Q4 2008 $111
Q3 2008 $107
Q2 2008 $109
Q1 2008 $102
Q4 2007 $109
Q3 2007 $106
Q2 2007 $108
Q1 2007 $101
Q4 2006 $95
Q3 2006 $92
Q2 2006 $90
Q1 2006 $88
Q4 2005 $74
Q3 2005 $82
Q2 2005 $82
Q1 2005 $77
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.412B $1.189B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.414B 34.76
Astellas Pharma (ALPMY) Japan $28.829B 14.14
Takeda Pharmaceutical (TAK) Japan $27.169B 7.98
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.853B 27.26
Grifols, S.A (GRFS) Spain $15.092B 19.09
Merck (MKGAF) Germany $13.293B 18.14
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.459B 20.68
Sage Therapeutics (SAGE) United States $9.292B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.044B 0.00
Catalent (CTLT) United States $7.834B 31.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 10.69
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.574B 9.09
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.818B 16.93
Tilray (TLRY) Canada $4.302B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $3.980B 0.00
United Therapeutics (UTHR) United States $3.335B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.191B 11.45
Arrowhead Pharmaceuticals (ARWR) United States $2.704B 407.43
PTC Therapeutics (PTCT) United States $2.503B 0.00
Xencor (XNCR) United States $2.493B 68.05
Zogenix (ZGNX) United States $2.019B 0.00
Portola Pharmaceuticals (PTLA) United States $1.763B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.672B 80.96
Ironwood Pharmaceuticals (IRWD) United States $1.639B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.607B 21.97
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.516B 0.00
Corcept Therapeutics (CORT) United States $1.226B 17.49
ArQule (ARQL) United States $1.132B 0.00
Aerie Pharmaceuticals (AERI) United States $1.103B 0.00
Radius Health (RDUS) United States $1.038B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.994B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.882B 0.00
Endo (ENDP) Ireland $0.792B 1.27
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.678B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Organogenesis Holdings (ORGO) United States $0.584B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.582B 0.00
TherapeuticsMD (TXMD) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.480B 0.00
ChemoCentryx (CCXI) United States $0.471B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Dermira (DERM) United States $0.460B 0.00
Siga Technologies (SIGA) United States $0.460B 1.08
BioSpecifics Technologies Corp (BSTC) United States $0.455B 22.94
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.434B 0.00
CV Sciences (CVSI) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Indivior (INVVY) United States $0.415B 1.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
CannTrust Holdings (CTST) Canada $0.404B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.396B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.382B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.346B 0.00
ImmunoGen (IMGN) United States $0.339B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Rafael Holdings (RFL) United States $0.294B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.238B 0.00
Recro Pharma (REPH) United States $0.224B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.223B 0.00
Lannett Co Inc (LCI) United States $0.219B 2.13
Ocular Therapeutix (OCUL) United States $0.206B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.197B 0.00
Redhill Biopharma (RDHL) Israel $0.181B 0.00
Calithera Biosciences (CALA) United States $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.148B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.140B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.113B 0.00
AgeX Therapeutics (AGE) United States $0.110B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.093B 0.00
Capnia (SLNO) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.090B 0.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 62.56
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Natural Alternatives (NAII) United States $0.081B 8.07
Cardiome Pharma (CORV) Canada $0.080B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
India Globalization Capital (IGC) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00